\-\ Texto\\:\\ \ \(0\)\
\-\ erythemetous\\,\\ tender\\ left\\ breast\ \(0\)\
\-\ whole\\ body\\ bone\\ scan\\ with\\ tc\\-99m\\ medronate\\-\\ \\ \ \(0\)\
\-\ abnormal\\ diffuse\\ soft\\ tissue\\ uptake\\ is\\ noted\\ with\\ the\\ left\\ breast\\.\\ \\ intense\\,\\ fusiform\\ uptake\\ is\\ noted\\ in\\ the\\ left\\ posterior\\ 11th\\ rib\\.\ \(0\)\
\-\ ct\\ chest\\ \\-\\ \\ skin\\ \\ and\\ trabecular\\ thickening\\ are\\ noted\\ within\\ the\\ left\\ breast\\.\\ \\ there\\ is\\ asymmetric\\ prominence\\ of\\ the\\ left\\ breast\\ parenchyma\\ without\\ evidence\\ of\\ abscess\\.\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\\ with\\ involvement\\ of\\ the\\ epidermis\\ \\-\\-\\-\\ mastectomy\ \(0\)\
\-\ differential\\ considerations\\ for\\ unilateral\\ breast\\ skin\\ and\\ trabecular\\ thickening\\:\ \(0\)\
\-\ \\	refractory\\ mastitis\ \(0\)\
\-\ \\	inflammatory\\ carcinoma\ \(0\)\
\-\ \\	post\\ radiation\\ mastitis\ \(0\)\
\-\ \\	lymphatic\\/svc\\ obstruction\ \(0\)\
\-\ \\	metastatic\\ disease\ \(0\)\
\-\ 36\\ y\\.o\\.\\ female\\ three\\ months\\ post\\-partum\\ presents\\ following\\ treatment\\ for\\ bilateral\\ mastitis\\ with\\ questionable\\ abnormality\\ on\\ mammogram\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mastitis\\:\\ 0\\.1726511438251377\ \(0\)\
\-\ breast\\:\\ 0\\.13706773668828487\ \(0\)\
\-\ trabecular\\:\\ 0\\.09599446187760294\ \(0\)\
\-\ erythemetous\\:\\ 0\\.07665668194753476\ \(0\)\
\-\ medronate\\-\\:\\ 0\\.07665668194753476\ \(0\)\
\-\ lymphatic\\/svc\\:\\ 0\\.07665668194753476\ \(0\)\
\-\ 11th\\:\\ 0\\.0646019483725792\ \(0\)\
\-\ uptake\\:\\ 0\\.05904318999468195\ \(0\)\
\-\ skin\\:\\ 0\\.057080503221547445\ \(0\)\
\-\ epidermis\\:\\ 0\\.055048798036334765\ \(0\)\
\-\ post\\-partum\\:\\ 0\\.055048798036334765\ \(0\)\
\-\ noted\\:\\ 0\\.052837074481372\ \(0\)\
\-\ thickening\\:\\ 0\\.050376079472927854\ \(0\)\
\-\ refractory\\:\\ 0\\.0459926773856551\ \(0\)\
\-\ fusiform\\:\\ 0\\.04502549794991403\ \(0\)\
\-\ mastectomy\\:\\ 0\\.04415520700594026\ \(0\)\
\-\ prominence\\:\\ 0\\.04395059398498205\ \(0\)\
\-\ whole\\:\\ 0\\.043750685130854235\ \(0\)\
\-\ considerations\\:\\ 0\\.04281476631179019\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.04246689383688845\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04212048121766725\ \(0\)\
\-\ questionable\\:\\ 0\\.041969864151323685\ \(0\)\
\-\ left\\:\\ 0\\.04156979431621368\ \(0\)\
\-\ infiltrating\\:\\ 0\\.040357662209311834\ \(0\)\
\-\ intense\\:\\ 0\\.03934833898102702\ \(0\)\
\-\ mammogram\\:\\ 0\\.038772257367625275\ \(0\)\
\-\ 36\\:\\ 0\\.037242773311419494\ \(0\)\
\-\ rib\\:\\ 0\\.03714977079736082\ \(0\)\
\-\ unilateral\\:\\ 0\\.03687658648228796\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0361050376509081\ \(0\)\
\-\ ductal\\:\\ 0\\.035026318966821325\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.03413190691951952\ \(0\)\
\-\ \\-\\:\\ 0\\.03185614710797154\ \(0\)\
\-\ parenchyma\\:\\ 0\\.03164668427297973\ \(0\)\
\-\ tender\\:\\ 0\\.030160094723904605\ \(0\)\
\-\ abnormality\\:\\ 0\\.027413547337656975\ \(0\)\
\-\ involvement\\:\\ 0\\.02723424918806797\ \(0\)\
\-\ obstruction\\:\\ 0\\.026203478683386395\ \(0\)\
\-\ inflammatory\\:\\ 0\\.025767964732104555\ \(0\)\
\-\ three\\:\\ 0\\.025048906333451394\ \(0\)\
\-\ radiation\\:\\ 0\\.0243847934744551\ \(0\)\
\-\ body\\:\\ 0\\.02413272793642682\ \(0\)\
\-\ differential\\:\\ 0\\.023590955037851562\ \(0\)\
\-\ abscess\\:\\ 0\\.023494228209863192\ \(0\)\
\-\ post\\:\\ 0\\.023398565504976467\ \(0\)\
\-\ diffuse\\:\\ 0\\.022495716698915782\ \(0\)\
\-\ y\\.o\\:\\ 0\\.021446777674666958\ \(0\)\
\-\ abnormal\\:\\ 0\\.02119210643752097\ \(0\)\
\-\ following\\:\\ 0\\.02108937179914042\ \(0\)\
\-\ scan\\:\\ 0\\.02080236052550416\ \(0\)\
\-\ months\\:\\ 0\\.020295141692957108\ \(0\)\
\-\ evidence\\:\\ 0\\.019482109420581546\ \(0\)\
\-\ metastatic\\:\\ 0\\.018705299161879047\ \(0\)\
\-\ bone\\:\\ 0\\.01846464940399887\ \(0\)\
\-\ soft\\:\\ 0\\.018095015339074347\ \(0\)\
\-\ bilateral\\:\\ 0\\.018033197646212556\ \(0\)\
\-\ chest\\:\\ 0\\.017780252174413206\ \(0\)\
\-\ tissue\\:\\ 0\\.017612358160457336\ \(0\)\
\-\ without\\:\\ 0\\.017495766663984003\ \(0\)\
\-\ posterior\\:\\ 0\\.01712729172784738\ \(0\)\
\-\ female\\:\\ 0\\.015276176273459422\ \(0\)\
\-\ presents\\:\\ 0\\.015179515613112399\ \(0\)\
\-\ treatment\\:\\ 0\\.015040147474790322\ \(0\)\
\-\ is\\:\\ 0\\.01466845508829719\ \(0\)\
\-\ within\\:\\ 0\\.014175055725096362\ \(0\)\
\-\ for\\:\\ 0\\.01268014171552548\ \(0\)\
\-\ disease\\:\\ 0\\.012145543836658296\ \(0\)\
\-\ there\\:\\ 0\\.011058396143173815\ \(0\)\
\-\ ct\\:\\ 0\\.01039394481210472\ \(0\)\
\-\ are\\:\\ 0\\.010129338021996536\ \(0\)\
\-\ \\:\\:\\ 0\\.009828476660788392\ \(0\)\
\-\ on\\:\\ 0\\.006294704455351549\ \(0\)\
\-\ the\\:\\ 0\\.006010838465375035\ \(0\)\
\-\ \\,\\:\\ 0\\.004708001139431085\ \(0\)\
\-\ with\\:\\ 0\\.004069710472691817\ \(0\)\
\-\ in\\:\\ 0\\.0036643237403500427\ \(0\)\
\-\ and\\:\\ 0\\.003130591404038582\ \(0\)\
\-\ of\\:\\ 0\\.0030392295860344806\ \(0\)\
\-\ \\.\\:\\ 0\\.0015434580911889684\ \(0\)\
